Corrigendum to ‘Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial’ [Vaccine 36 (2018) 4278–4286]
2018 ◽
Vol 187
(9)
◽
pp. 1856-1862
◽
2019 ◽
Vol 33
(3)
◽
pp. 243-248